Q1 2024 Holdings
Filed 2024-05-15 | 12 holdings | $751.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $187.9M | 2,750,804 | 25.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $107.9M | 1,436,964 | 14.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $95.1M | 1,435,950 | 12.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $80.8M | 1,476,974 | 10.8% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $78.6M | 1,982,016 | 10.5% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $70.0M | 2,119,598 | 9.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $55.3M | 832,198 | 7.4% |
| Xencor Inc(XNCR) | COM | 98401F105 | $24.6M | 1,109,650 | 3.3% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $17.9M | 473,200 | 2.4% |
| Elevation Oncology Inc | COM | 28623U101 | $12.0M | 2,332,928 | 1.6% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $10.6M | 465,000 | 1.4% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $10.5M | 79,600 | 1.4% |